Clinical Trial Detail

NCT ID NCT02748135
Title A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Oncurious NV
Indications

neuroblastoma

alveolar rhabdomyosarcoma

medulloblastoma

Ewing sarcoma

Therapies

TB-403

Age Groups: adult child

No variant requirements are available.